Dysport® Adult Lower Limb Spasticity Follow-on Study
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to assess the long term safety of Dysport in
hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury over
repeated treatment cycles.
Phase:
Phase 3
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA